Real-World Use of Recombinant Factor IX Fusion Protein in Previously Untreated Patients with Congenital Hemophilia B from the ATHN 8 Study

Author(s):
Courtney Thornburg, Martin Chandler, Lynn Malec, Matthew Manuel, Carrie O’Neill, Michael Recht, Elizabeth Taggart, Hongseok Kim, Vindhi Desai, Hiren Shah, Shannon Carpenter
Publication:
Thrombosis & Hemostasis Summit of North America (THSNA) 2024
Date:
April 4-6, 2024
Topics:
recombinant factor IX, previously untreated patients, PUPs, hemophilia B, ATHN 8

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.